1 Relationship of Hypertensive Retinopathy with Mean Platelet Volume Among Hypertensive Patients.

2 the relationship between microvascular complications and depression in patients with type 2 diabetes mellitus who use insulin

3 evaluation of oct on retinopathy induced by tunicamycin in rats

4 Intestinal perforation after intravitreal low dose ranibizumab injection for the treatment of type 1 retinopathy of prematurity: A case report

5 Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats.

6 An Evaluation System of Fundus Photograph-Based Intelligent Diagnostic Technology for Diabetic Retinopathy and Applicability for Research.

7 Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence.

8 Treatment of central serous chorioretinopathy with topical NSAIDs

9 Treatment of central serous chorioretinopathy with topical NSAIDs

10 Treatment of central serous chorioretinopathy with topical NSAIDs

11 Endogenous Clostridium perfringens Panophthalmitis with Potential Entry Port from Diverticulitis Exacerbated by Proliferative Diabetic Retinopathy

12 Use of Expectation Disconfirmation Theory to Test Patient Satisfaction with Asynchronous Telemedicine for Diabetic Retinopathy Detection

13 Body Mass Index: A Risk Factor for Retinopathy in Type 2 Diabetic Patients

14 Awareness of diabetes and diabetic retinopathy among a group of diabetic patients in main public hospitals in Damascus, Syria during the Syrian crisis.

15 Disease risk factor control and drug intervention in diabetic retinopathy

16 Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy.

17 Metabolic characterization of diabetic retinopathy: An <sup>1</sup>H-NMR-based metabolomic approach using human aqueous humor

18 Retinal blood oxygen saturation and aqueous humour biomarkers in early diabetic retinopathy

19 Multicolor imaging in central serous chorioretinopathy – a quantitative and qualitative comparison with fundus autofluorescence

20 Visualizing Deep Learning Models for the Detection of Referable Diabetic Retinopathy and Glaucoma

21 Prevalence and factors associated with diabetic retinopathy among diabetic patients at Arbaminch General Hospital, Ethiopia: Cross sectional study.

22 Association of IGF1 and VEGFA polymorphisms with diabetic retinopathy in Pakistani population.

23 -429 T/C and -374 T/A Polymorphisms in Receptor Advanced Glycation Endproducts (RAGE) gene in Type 2 Diabetic Patients with Diabetic Retinopathy at the Dr. Sardjito General Hospital Yogyakarta

24 Risk of development of treated retinopathy of prematurity in very low birth weight infants.

25 Glycated Haemoglobin and Diabetic Retinopathy in Type 2 Diabetic Patients in HRH Princess Maha Chakri Sirindhorn Medical Center

26 Aiding the Diagnosis of Diabetic and Hypertensive Retinopathy Using Artificial Intelligence-Based Semantic Segmentation.

27 Vitrectomy for proliferative diabetic retinopathy

28 Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study.

29 Artificial intelligence with deep learning technology looks into diabetic retinopathy screening

30 Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial.

31 [Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab].

32 Changes in components of the neurovascular unit in the retina in a rat model of retinopathy of prematurity.

33 Characteristics of 'sawtooth shunt' following anti-vascular endothelial growth factor for aggressive posterior retinopathy of prematurity.

34 Functional result and visual outcome in early versus conventional treatment of retinopathy of prematurity.

35 Clinical Predictors of Diabetic Retinopathy Progression; A Systematic Review.

36 The prevalence and risk factors of diabetic retinopathy in selected primary care centers during the 3-year screening intervals.

37 The prevalence and risk factors of diabetic retinopathy in selected primary care centers during the 3-year screening intervals

38 QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES FOR OBJECTIVE CLASSIFICATION AND STAGING OF DIABETIC RETINOPATHY.

39 Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy.

40 Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.

41 Oxidative Stress, Ocular Disease and Diabetes Retinopathy.

42 Hydroxychloroquine Retinopathy in the Era of Advanced Imaging Modalities

43 Additional Analyses to Confirm Relationship of Hydroxychloroquine Blood Levels to Retinopathy: Comment on the Article by Petri et al

44 Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy

45 Hydroxychloroquine Induced Retinopathy: A Case Series

46 Vision-related quality of life and visual function following vitrectomy for proliferative diabetic retinopathy

47 Retinal Nerve Fiber Layer Thickness in Early-Stage Diabetic Retinopathy With Vitamin D Deficiency

48 [Visual function analysis of diabetic retinopathy using a contrast sensitivity analyser and usefulness of nicardipine hydrochloride]

49 Contrast sensitivity among patients with birdshot chorioretinopathy

50 Insights into stem cell therapy for diabetic retinopathy: A bibliometric and visual analysis

51 incidence of type-1 retinopathy of prematurity in premature babies born small for gestational age

52 relevant risk factors analysis of diabetic retinopathy in patients with type 2 diabetes mellitus from community

53 intravitreal bevacizumab in aggressive posterior retinopathy of prematurity

54 angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy

55 the association between diabetic retinopathy and levels of ischemia-modified albumin, total thiol, total antioxidant capacity, and total oxidative stress in serum and aqueous humor

56 “oxygen with love” and diode laser treatment decreases comorbidity and avoidable blindness due to retinopathy of prematurity: results achieved in the past 12 years

57 neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy

58 incidence of retinopathy of prematurity in a tertiary care center of northeast india

59 ranibizumab in patients with dense cataract and proliferative diabetic retinopathy with rubeosis

60 antiretinal antibody- proven autoimmune retinopathy

61 intravenous sodium fluorescein enhances the visibility of vitreous during vitrectomy surgery for diabetic retinopathy fluoresceína sódica intravenosa aumenta a visibilidade do vítreo durante a cirurgia de vitrectomia para retinopatia diabética

62 effect of ranirestat, a new aldose reductase inhibitor, on diabetic retinopathy in sdt rats

63 update on diagnosis and treatment of diabetic retinopathy: a consensus guideline of the working group of ocular health (spanish society of diabetes and spanish vitreous and retina society)

64 incidencia de la retinopatía de la prematuridad incidence of retinopathy of prematurity

65 the combined extract of purple waxy corn and ginger prevents cataractogenesis and retinopathy in streptozotocin-diabetic rats

66 the association of type 2 diabetes mellitus with cerebral gray matter volume is independent of retinal vascular architecture and retinopathy

67 newly diagnosed diabetes mellitus patients presenting with proliferative diabetic retinopathy as an initial sign

68 retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection

69 combined surgery for neovascular angle-closure glaucoma secondary to proliferative diabetic retinopathy

70 roles of elevated intravitreal il-1β and il-10 levels in proliferative diabetic retinopathy

71 curative effect of extra-panretinal photocoagulation on proliferative diabetic retinopathy during vitreous operation

72 community care for diabetic retinopathy and glaucoma in india: a panel discussion

73 spontaneous closure of a full-thickness macular hole associated with proliferative diabetic retinopathy and persistent vitreomacular traction

74 pattern visual evoked potential changes in diabetic patients without retinopathy

75 radiation optic neuropathy and retinopathy with low dose (20 gy) radiation treatment

76 role of electrophysiology in the early diagnosis and follow-up of diabetic retinopathy

77 epigenetic modifications and diabetic retinopathy

78 screening for diabetic retinopathy: the optometrist’s perspective

79 comparing carotid intima-media thickness in type 2 diabetes between patients with and without retinopathy

80 phytochemicals: target-based therapeutic strategies for diabetic retinopathy

81 intravitreal ranibizumab for stage iv proliferative sickle cell retinopathy: a first case report

82 noninvasive retinal markers in diabetic retinopathy: advancing from bench towards bedside

83 a socioeconomic and behavioral survey of patients with difficult-to-control type 2 diabetes mellitus reveals an association between diabetic retinopathy and educational attainment

84 antioxidative stress effect of probucol for nonproliferative diabetic retinopathy

85 assessment of choroidal thickness of central serous chorioretinopathy by optical coherence tomography with enhanced depth imaging

86 abnormal complement activation and inflammation in the pathogenesis of retinopathy of prematurity

87 a case of uveal colobomas showing marked left-right difference in diabetic retinopathy

88 comparative study of visual functions in premature pre-school children with and without retinopathy of prematurity

89 diabetic retinopathy: an epidemic at home and around the world

90 pronerve growth factor induces angiogenesis via activation of trka: possible role in proliferative diabetic retinopathy

91 seizure related valsalva-like retinopathy

92 macular integrity assessment and fixation analysis in chronic central serous chorioretinopathy

93 macular ischaemia as a marker for nephropathy in diabetic retinopathy.

94 neuroprotection as a therapeutic target for diabetic retinopathy

95 foveal slope measurements in diabetic retinopathy: can it predict development of sight-threatening retinopathy? sankara nethralaya diabetic retinopathy epidemiology and molecular genetics study (sn-dreams ii, report no 8)

96 clinical evidence and potential mechanisms of chinese medicines for the treatment of diabetic retinopathy

97 system of the ophthalmologic help premature children with retinopathy of prematurity in the central region of russia

98 nd:yag laser for preretinal hemorrhage in diabetic retinopathy

99 differentially expressed micrornas in the development of early diabetic retinopathy

100 diabetic retinopathy: a new approach to drug treatment

101 erratum to “hyperglycemia induces toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy”

Keyword Connections

Journals

Research Groups

Bibliographies